Simon Pernot
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 76
- Colorectal Cancer Treatments and Studies 38
- Cancer Immunotherapy and Biomarkers 23
- Pancreatic and Hepatic Oncology Research 14
-
- Gastric Cancer Management and Outcomes 15
- Co-authors
- Julien Taı̈eb (52 shared papers)Magali Terme (9 shared papers)Éric Tartour (9 shared papers)Elie Marcheteau (7 shared papers)Orianne Colussi (5 shared papers)Thibault Voron (6 shared papers)Nadine Benhamouda (4 shared papers)Anne‐Laure Pointet (6 shared papers)
In The Last Decade
Simon Pernot
111 papers receiving 4.7k citations
Simon Pernot's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 2.4k
- Hepatology 324
- Pulmonary and Respiratory Medicine 837
- Immunology 429
- Cancer Research 248
Countries citing papers authored by Simon Pernot
This map shows the geographic impact of Simon Pernot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Pernot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Pernot more than expected).
Fields of papers citing papers by Simon Pernot
This network shows the impact of papers produced by Simon Pernot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Pernot. The network helps show where Simon Pernot may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Pernot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors Hit paper breakdown → | 2015 | 1003 |
| 2 | VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer Hit paper breakdown → | 2012 | 568 |
| 3 | Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression Hit paper breakdown → | 2021 | 464 |
| 4 | 2014 | 277 | |
| 5 | 2015 | 235 | |
| 6 | 2016 | 169 | |
| 7 | 2015 | 141 | |
| 8 | 2021 | 114 | |
| 9 | 2014 | 109 | |
| 10 | 2014 | 109 | |
| 11 | 2018 | 108 | |
| 12 | 2018 | 106 | |
| 13 | 2018 | 103 | |
| 14 | 2019 | 93 | |
| 15 | 2010 | 66 | |
| 16 | 2022 | 57 | |
| 17 | 2018 | 52 | |
| 18 | 2017 | 48 | |
| 19 | 2019 | 48 | |
| 20 | 2020 | 45 |
About Simon Pernot
Simon Pernot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Cancer Research, having authored 124 papers that have together received 4.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (38 papers), Cancer Immunotherapy and Biomarkers (23 papers), Gastric Cancer Management and Outcomes (15 papers), Pancreatic and Hepatic Oncology Research (14 papers), Colorectal and Anal Carcinomas (13 papers), Cervical Cancer and HPV Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (2.4k citations), Hepatology (324 citations), Pulmonary and Respiratory Medicine (837 citations), Immunology (429 citations) and Cancer Research (248 citations). Simon Pernot has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Julien Taı̈eb, Magali Terme, Éric Tartour, Elie Marcheteau, Orianne Colussi, Thibault Voron, Nadine Benhamouda, Anne‐Laure Pointet, Olivier Dubreuil and Aziz Zaanan. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, Digestive and Liver Disease and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.